Disc Medicine (IRON) Short-term Investments (2021 - 2026)

Disc Medicine (IRON) has 5 years of Short-term Investments data on file, last reported at $641.2 million in Q1 2026.

• Quarterly Short-term Investments rose 12.11% year-over-year to $641.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $641.2 million (up 12.11% YoY) and the FY2025 annual result came in at $700.0 million, up 135.34% from the prior year.
• Short-term Investments retreated to $641.2 million in Q1 2026 per IRON's latest filing, from $700.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $700.0 million in Q4 2025 and bottomed at $323000.0 in Q1 2022.
• The 4-year median for Short-term Investments is $475.3 million (2025), against an average of $413.8 million.
• The widest annual swing landed in 2025, when Short-term Investments surged 137.26%; it then grew 12.11% in 2026.
• Tracing IRON's Short-term Investments over 4 years: stood at $323000.0 in 2022, then soared by 91988.85% to $297.4 million in 2024, then surged by 135.34% to $700.0 million in 2025, then slipped by 8.39% to $641.2 million in 2026.
• Per Business Quant, the three latest IRON Short-term Investments figures stand at $641.2 million (Q1 2026), $700.0 million (Q4 2025), and $475.3 million (Q3 2025).

Peer Comparison